Summary
Intuitive Surgical, Inc. (ISRG) reported solid financial results for the first quarter of 2015, demonstrating continued growth in total revenue, driven by increased procedure volumes and system shipments. The company's strategic focus on expanding minimally invasive surgery (MIS) adoption through its da Vinci Surgical Systems is showing positive traction, with a 13% increase in da Vinci procedures globally and an 11% increase in the U.S. The introduction of the da Vinci Xi Surgical System appears to be well-received, contributing to a significant increase in system revenue. While recurring revenue, comprising instruments, accessories, and service, continues to be a substantial portion of the company's top line (74% of total revenue), its growth rate slightly moderated compared to system revenue. The company is actively managing its product pipeline and international expansion, though it faces ongoing challenges including potential impacts from foreign currency fluctuations and legal proceedings related to product liability claims. Despite these headwinds, ISRG maintains a strong balance sheet with ample cash reserves, supporting its ongoing investments in research and development and strategic initiatives.
Financial Highlights
46 data points| Revenue | $532.10M |
| Cost of Revenue | $195.30M |
| Gross Profit | $336.80M |
| R&D Expenses | $44.40M |
| SG&A Expenses | $162.00M |
| Operating Expenses | $206.40M |
| Operating Income | $130.40M |
| Net Income | $97.00M |
| EPS (Basic) | $0.29 |
| EPS (Diluted) | $0.29 |
| Shares Outstanding (Basic) | 330.30M |
| Shares Outstanding (Diluted) | 339.30M |
Key Highlights
- 1Total revenue increased by 15% to $532.1 million in Q1 2015 compared to Q1 2014, primarily driven by higher system sales and procedure growth.
- 2Global da Vinci procedures increased by 13% year-over-year, with a notable 11% growth in the U.S., indicating expanding adoption of minimally invasive surgery.
- 3System revenue saw a significant increase of 33% to $141.0 million, boosted by the positive market response to the new da Vinci Xi Surgical System and increased shipments.
- 4Recurring revenue, from instruments, accessories, and service, grew 9% to $391.1 million, representing 74% of total revenue, underscoring the ongoing value derived from the installed base of da Vinci systems.
- 5Operating income saw a substantial increase of 130% to $130.4 million, despite product liability charges, reflecting strong revenue growth and improved operational efficiency.
- 6The company repurchased approximately $14.7 million of its common stock during the quarter, demonstrating a commitment to returning value to shareholders and managing its capital structure.
- 7Intuitive Surgical maintains a robust cash position, with $2.7 billion in cash, cash equivalents, and investments as of March 31, 2015, providing significant financial flexibility for future growth and investments.